Navigation Links
Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
Date:12/21/2007

me the centerpiece of Home Healthcare Solutions, which will form part of Philips Healthcare as of January 1, 2008.

Respironics is a leading developer, manufacturer and distributor of innovative products and programs that serve the global sleep and respiratory markets. Focusing on emerging market needs, the Company is committed to providing valued solutions to help improve outcomes for patients, clinicians and health care providers. Respironics markets its products in 141 countries and employs more than 5,300 associates worldwide. Further information can be found on the Company's Web site: http://www.respironics.com.

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in healthcare, lighting and consumer lifestyle, delivering products, services and solutions through the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 128,000 employees in more than 60 countries worldwide. With sales of EUR 27 billion in 2006, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, personal care and home appliances, as well as consumer electronics. News from Philips is located at http://www.philips.com/newscenter.

FORWARD-LOOKING STATEMENT

This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Respironics and certain of the plans and objectives of Respironics with respect to these items, including without limitation completion of the tender offer and merger. Completion of the ten
'/>"/>

SOURCE Respironics Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. British Royal highlights anesthesia crisis in the developing world
2. Unilens Vision Reports Record First Quarter Earnings and Royalty Income
3. Royalty Pharma Acquires a Portion of Northwestern Universitys Royalty Interest in Lyrica(R) for $700 Million
4. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
5. Audio from Medialink and Philips: Americas Dirty Mouths
6. AUDIO from Medialink and Philips: Getting Rid of the Uninvited Holiday Guests on Your Toothbrush
7. North Carolina Coalition on Donation Selects Corder Philips for Newest Campaign
8. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
9. Kaiser Permanente Named Green Electronics Champion by EPA, Green Electronics Council
10. BioElectronics Corporation Receives 2007 Economic Development Innovator of the Year Award
11. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...irstCall/ -- Medifast, Inc. (NYSE: MED ), a lead...announced they,ve been named a Future 50 winner by... and 2009 winner of this award. , , The Future...anies in the Greater Baltimore area based on emplo...mber 16, 2008 that The Company expects revenues in...
(Date:1/7/2009)... Tools , To Manage Family,s Dental Care and Oral...s Comprehensive Web Portal , , CHICAGO, Jan. 7...Moms are the ones who make most decisions in Ameri...n it comes to a family,s overall dental and oral h...usy Moms were not sure where to turn for help in f...
(Date:1/7/2009)...d to the memory and scientific accomplishments of ...iogenesis and vasculogenesis and shed light on the... the newly released special double issue (Volume 6...includes a series of papers that reflect the resea...entists of his generation. Lymphatic Research and...
(Date:1/7/2009)...hild born with cleft lip and palate often have one...ives a normal life. For some, this year,s resolut...teering and philanthropy, members of the American ...009 by demonstrating, "it is better to give than t...eral charitable organizations to donate their reco...
Breaking Medicine News(10 mins):Health News:Medifast Named Baltimore SmartCEO Future 50 Company for Second Time 2Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 2Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 3Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 4Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 5Health News:Festschrift Issue honoring Judah Folkman, M.D., in Lymphatic Research and Biology 2Health News:New year brings new hope to children born with cleft lip, palate 2
... caught in the throes of a bizarre incident that t... 13th, around 10:30 pm, the whole of the ICU was h...ve wielded a gun in his hand, and demanded that hi...ry, not be shifted from the ICU to the ward. Th...
...ity School of Medicine developed a breed of resear...l//. It studies how "good" cholesterol is used by...okes. According to John S. Parks, Ph.D., from Wak...Medicine, “Being able to develop drugs to raise le...
...ollege of Wisconsin Center for Patient Care and Ou...breast cancer survivors, who were under the care o...cialist, had a better chance of beating their tumo...e researchers found that about two-thirds of elder...
...e level of awareness about the pill among women. I... the Progestogen-only// pill are not aware that it...me of intake. Due to this many women are at risk...nducted among more than 5,700 women throughout Eur...
Other Medicine News:
(Date:1/6/2009)...6 Sequella, Inc., a cli...iseases of epidemic potential, announced today tha... of tuberculosis (TB), was the first drug approved...m contract to Dynport Vaccine Company LLC and Quin...National Institute of Allergy and Infectious Disea...
(Date:1/6/2009)... Jan. 6 Pacira Pharmaceuticals, In...y, announced today that enrollment,has been compl...luate the,safety and efficacy of a single intraop...caine) for prolonged postoperative analgesia. ,...and in total knee,arthroplasty (TKA) are expected...
(Date:1/5/2009)...Newswire/ -- Cylene Pharmaceuticals announced toda...f its oral CK2 protein kinase inhibitor, CX-4945, ...s disease, or multiple myeloma. The primary endpoi...ation of safety, tolerance and PK properties of CX... II trials. In addition, multiple mechanism-relate...
(Date:1/5/2009)... Jan. 5 Women undergoing in vitro,...on to help support early,pregnancy, but the intra...ion,can be painful for patients. Formulations of...d by subcutaneous injection or vaginal suppository...lerance. , With patient well-being a consta...
Breaking Medicine Technology:Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2 Mobile Imaging Innovator Mobile Diagnostic Centers LP Appoints New CEO 3A Mobile Imaging Development 26apos 3Bs Limited Partnership Mobile Diagn 28467 1 Mobile Imaging Innovator Mobile Diagnostic Centers LP Appoints New CEO 3A Mobile Imaging Development 26apos 3Bs Limited Partnership Mobile Diagn 28467 2Research shows aerobic exercise combined with resistance training improves glucose control in diabetics 28465 1Research shows aerobic exercise combined with resistance training improves glucose control in diabetics 28465 2New regulatory mechanism discovered for cell identify and behavior in forming organs 5688 1New regulatory mechanism discovered for cell identify and behavior in forming organs 5688 2New regulatory mechanism discovered for cell identify and behavior in forming organs 5688 3Protect Your Cats From Fleas All Year Round With New Vectra for Cats 28R 29 28460 1Protect Your Cats From Fleas All Year Round With New Vectra for Cats 28R 29 28460 2Protect Your Cats From Fleas All Year Round With New Vectra for Cats 28R 29 28460 3Protect Your Cats From Fleas All Year Round With New Vectra for Cats 28R 29 28460 4
...l.--(BUSINESS WIRE)--Jun 21, 2007 - BioSante,Pharm... on the,Women,s Health Initiative (WHI) Coronary A... England Journal of Medicine (NEJM).,The study fou...received a standard dose of estrogen therapy had s... the end of the study period,compared with those t...
...exas--(BUSINESS WIRE)--Jun 21, 2007 - Opexa,Therap...the,development and commercialization of cell ther...n open-label Phase I/II,extension clinical trial o... for multiple sclerosis (MS). In this one-year,8-...tting (RRMS),and secondary progressive (SPMS) subj...
Other Medicine Technology:New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 2New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 3New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 4Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 2Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 3Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 4Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 5
4Fr, 5Fr & 6Fr diagnostic electrophysiology catheters with fixed curves.
Inquiry 4Fr, 5Fr and 6Fr diagnostic electrophysiology catheters offer simple, precise distal control with it's patented Easy-Hand steering mechanism.
The Arrow 2 Fr. QuadPolar electrode catheter and triple lumen guide system is designed for faster and easier electrophysiology studies. The 2 Fr. QuadPolar catheter is highly torqueable, radiopaque,
...nkle/Brachial Index (ABI) testing, Nicolet Vascula...ion. It includes a 10-minute compact disk ABI trai...er with a CD drive. It shows the step-by-step proc...ion on the materials that are needed, and indicate...
Medicine Products: